Conagra Buying Pinnacle Foods in $10.9 Billion Deal
*By Justin Chermol*
Shares of Conagra Brands and Pinnacle Foods dropped Wednesday after the companies announced an $11 billion merger that would create a giant in the frozen food industry.
The cash and stock deal, which brings together the Healthy Choice and Bird’s Eye, values Pinnacle at $68 a share, only a few cents higher than where the stock closed on Tuesday.
With grocery giants like Walmart, Kroger, and Costco, putting pressure on packaged food makers to reduce prices, companies like Conagra and Pinnacle have been forced to consolidate. Further weighing on these companies is the increased awareness of health and nutrition over the past decade, which has driven down sales of packaged, frozen, non-perishable foods.
But both Conagra and Pinnacle have recently debuted healthier frozen food options and reduced prices, helping grow sales in their most recent quarters. A combined company would have annual revenues of about $11 billion.
Student loan borrowers have the ability to earn retirement funds pegged to their payments – and the company Summer might be bringing it to your workplace.
It might not be what investors want to hear… but bringing down inflation could mean interest rates stay higher for (even) longer. But it's not all downside.
President Joe Biden and Chinese President Xi Jinping have discussed Taiwan, artificial intelligence and security issues in a call meant to demonstrate a return to regular leader-to-leader dialogue between the two powers.
April is Earth month, and while the green revolution might feel far away, the founder of climate VC Siam Capital says it’s on it’s way, and, even better: it won't cost you more.
From snow in April to heatwaves in December, it’s hard to plan a trip in a climate change world. Startup Sensible Weather thinks weather-based travel reimbursements are the solution.
Between corporate debt and the widening gap between ‘the haves and the have nots,’ there are reasons to be cautious about the economy, even with interest rate cuts on their way.
If the A.I. hype hasn’t given you enough of a reason to be excited (and a little terrified), the CEO of Zapata AI says the next frontier is designing bridges or creating pharmaceutical drugs.
